About TransAxon
TransAxon is a company based in Auckland (New Zealand) founded in 2021 by Connor Clemett, Yunli Lu, and Michael Witbrock. TransAxon operates in a competitive market with competitors including NeuroKaire, Manus Neuro, Luciole Medical, Rhaeos and RetiSpec, among others.
- Headquarter Auckland, New Zealand
- Founders Connor Clemett, Yunli Lu, Michael Witbrock
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Transaxon Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TransAxon
Detailed funding history for TransAxon
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TransAxon
Investment portfolio details for TransAxon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TransAxon
Detailed financials for TransAxon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transaxon Comparisons
Peer comparison for TransAxon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TransAxon
TransAxon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroKaire, Manus Neuro, Luciole Medical, Rhaeos and RetiSpec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| Locked | Locked | Locked |
Devices for neuromotor impairment biomarkers are provided.
|
|
| Locked | Locked | Locked |
Brain monitoring devices and analytics platforms are developed and provided.
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Brain activity data is analyzed digitally for medical providers.
|
Detailed competitors of TransAxon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transaxon
Complete news archive for TransAxon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TransAxon
TransAxon was founded in 2021.
TransAxon is headquartered in Auckland, New Zealand.
Michael Witbrock is the current CEO of TransAxon. They have also founded this company.
TransAxon was founded in 2021 in Auckland, New Zealand, as a provider in the neurotechnology sector. Brain-computer interfaces for neuroprosthetics are offered, with AI-BCIs designed to connect physiological psychology and artificial intelligence for brain repair. Non-invasive interfaces are constructed to support these functions, focusing on practical applications in medical and rehabilitative contexts. Operations center on advancing accessible neuroprosthetic solutions.
TransAxon's top competitors include NeuroKaire, Brain.Space and RetiSpec.